Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Substituted Enamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114276286A reveals a novel one-pot synthesis of N,N-disubstituted-alpha,beta-unsaturated enamines using DMSO and base, offering significant cost reduction in API manufacturing.
Patent CN111848450A discloses a mild route to acyloxyenamines. This method offers high yields and avoids hazardous oxidants for scalable manufacturing.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.
Patent CN109232284B reveals a novel acid-catalyzed route for polysubstituted enamine aldehydes, offering high yields and simplified purification for pharmaceutical manufacturing.
Patent CN115925692A details Rh-catalyzed C-H activation for trifluoromethyl enamines. High yields, scalable process for drug discovery.
Discover how rhodium-catalyzed C-H activation enables high-yield trifluoromethyl enamine synthesis with 80%+ yields, reducing supply chain risks for drug development.
Solve low-yield enamine synthesis challenges with this rhodium-catalyzed method. Achieve >80% yields, broad substrate tolerance, and scalable production for pharmaceutical R&D.